Medical News

RSS

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).

1 Sep 2009

Demand for Imprivata's OneSign Platform solution growing

Imprivata®, Inc., the employee access management company and largest provider of healthcare single sign-on (SSO), today announced that it continues to see strong demand for its OneSign Platform solution from the healthcare industry's leading organizations.

1 Sep 2009

CompAnalyst helps healthcare providers gain insight into competitive salary data

Salary.com, Inc., a leading provider of on-demand compensation, payroll and talent management solutions, is providing several healthcare providers with on-demand market pricing software to help them gain insight into competitive salary data.

1 Sep 2009

Caregivers call for comprehensive process to verify signatures

Home care workers called for a hand-examination of each signed card submitted by an organization seeking to decertify the workers' union, saying they had been subjected to lies, coercion, and fraud.

1 Sep 2009

USAction affiliates to participate in rallies in support of affordable health care

As Congress prepares to return to work, USAction affiliates and partner organizations are participating in at least 102 rallies and other events in 20 states in support of quality, affordable health care with a public health insurance option.

1 Sep 2009

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, helped raise approximately $1.1 million during the Napa Valley Tour de Cure, which took place on May 3 to benefit the American Diabetes Association.

1 Sep 2009

Neurobiological Technologies to liquidate assets and dissolve corporation

Neurobiological Technologies, Inc. (NTI(R))(the "Company") today announced that its board of directors has determined, after consideration of potential strategic alternatives, that it is in the best interests of the Company and all its stockholders to liquidate the Company's assets and to dissolve the Company.

1 Sep 2009

InfuSystem Holdings appoints Board Chairman as new Chief Executive Officer

InfuSystem Holdings, Inc., announced today that its Board of Directors has accepted the resignation of Mr. Steve Watkins as President, Chief Executive Officer and Board Member, effective September 7, 2009. Sean McDevitt, Chairman of the Board, will immediately take over the additional role of Chief Executive Officer.

1 Sep 2009

MultiGEN Diagnostics launches new technology for clinical testing in molecular diagnostics

San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.

1 Sep 2009

Traditional lipid risk factors to be strong predictors of cardiovascular events according to a study

For patients with established heart disease who were treated with a statin, 18 novel biomarkers including C-reactive protein (CRP) did not predict future cardiovascular events such as heart attack and stroke, according to results of an analysis presented today at the 2009 European Society of Cardiology Congress in Barcelona, Spain.

1 Sep 2009

Cannasat Therapeutics announces completion of second tranche of prospectus offering

Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.

1 Sep 2009

Clinical Healthcare Enterprise Framework to help healthcare HR for effective talent management

Salary.com, Inc. (NASDAQ: SLRY), a leading provider of on-demand compensation, payroll and talent management solutions, announced today that it has added the Clinical Healthcare Enterprise Framework to its growing Job Model and Competency Library of more than 1,200 job models and 1,300 functional competencies, which provide data and structure for typical jobs at all levels of an organization. The framework will enable healthcare HR professionals to create job roles easily, deliver job models quickly, and power their talent management systems.

1 Sep 2009

Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the UBS Global Life Sciences Conference in New York at 11:00 a.m. Eastern Time on Monday, September 21, 2009. Mr. Kazimi will provide an update on the Company and its Caldolor product, which Cumberland is preparing to launch following its recent approval by the Food and Drug Administration.

1 Sep 2009

Poll finds more confidence about paying for health care; young adults most supportive of reform

A new survey finds growing confidence in Americans' ability to pay for health care costs. Meanwhile, young adults are the group most supportive of health reform.

1 Sep 2009

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Seegene today released a new influenza A sub-type screening test, Seeplex FluA ACE Subtyping, that enables simultaneous detection of pandemic novel influenza A (H1N1), seasonal human influenza A H1, seasonal human influenza A H3 and avian influenza A H5 in a single reaction.

1 Sep 2009

Nighttime acid reflux symptoms impair sleep quality

There has been much debate about the relationship between gastroesophageal reflux disease (GERD) and sleep. Three new studies in Clinical Gastroenterology and Hepatology explore GERD's effect on sleep quality and the health-care system as well as how a widely prescribed sleeping pill may mask the disease.

1 Sep 2009

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

A team of researchers from The Wistar Institute have shown that a large non-coding RNA in mammals and yeast plays a central role in helping maintain telomeres, the tips of chromosomes that contain important genetic information and help regulate cell division. Since this RNA also facilitates the formation of DNA at telomeres-a process that can protect aging cells and destabilize tumor cells-manipulating its expression may be useful in treating cancer and other diseases.

1 Sep 2009

State wrap: Mental illness in Arizona, stimulus "windfall" in Texas, Medicaid expansion in Nebraska

Local newspapers report on health care issues including mental health in Arizona, the stimulus "windfall" in Texas and a family health insurance plan in Nebraska.

1 Sep 2009

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barr- syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and U. S. Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).

1 Sep 2009

VBI researcher receives grant from NIGMS for developing network-based models of infectious diseases

A researcher from the Virginia Bioinformatics Institute (VBI) at Virginia Tech has received a grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH), to support ongoing work to develop high-performance computer models for the study of very large networks.

1 Sep 2009

Medical News

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

Demand for Imprivata's OneSign Platform solution growing

CompAnalyst helps healthcare providers gain insight into competitive salary data

Caregivers call for comprehensive process to verify signatures

USAction affiliates to participate in rallies in support of affordable health care

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Neurobiological Technologies to liquidate assets and dissolve corporation

InfuSystem Holdings appoints Board Chairman as new Chief Executive Officer

MultiGEN Diagnostics launches new technology for clinical testing in molecular diagnostics

Traditional lipid risk factors to be strong predictors of cardiovascular events according to a study

Cannasat Therapeutics announces completion of second tranche of prospectus offering

Clinical Healthcare Enterprise Framework to help healthcare HR for effective talent management

Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference

Poll finds more confidence about paying for health care; young adults most supportive of reform

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Nighttime acid reflux symptoms impair sleep quality

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

State wrap: Mental illness in Arizona, stimulus "windfall" in Texas, Medicaid expansion in Nebraska

VAERS calls for reporting of GBS cases following 2009 H1N1 flu vaccination

VBI researcher receives grant from NIGMS for developing network-based models of infectious diseases

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News